CompaniesByCap
MCRB
Seres Therapeutics, Inc. (MCRB)
NASDAQ · Healthcare

Seres Therapeutics, Inc. Cash Flow 2015–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
Operating Activities
Operating Cash Flow1.1M-148.6M-117.4M-228.8M6.7M-93.6M-76.5M-62.9M-75.5M43.9M
Depreciation & Amort.4.1M5.5M6.2M6.6M5.9M6.6M7.6M7.9M7.3M4.2M
Investing Activities
Capital Expenditure252,000380,0008.0M9.8M9.6M591,0001.0M1.9M4.7M21.5M
Free Cash Flow865,000-149.0M-125.3M-238.6M-2.9M-94.2M-77.5M-64.8M-80.2M22.4M
Financing Activities
Dividends Paid
Stock Buybacks33,000

Seres Therapeutics, Inc. Cash Flow — FAQ

Seres Therapeutics, Inc. (MCRB) cash flow over the last 11 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see MCRB's cash flow history?

The chart and table above show Seres Therapeutics, Inc.'s cash flow by year and by quarter, including the growth rate.